Serbian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

hyperlipidemias/tyrosine

Веза се чува у привремену меморију
11 резултати

Protein tyrosine phosphatase inhibitors and methods of use thereof

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
FIELD OF THE INVENTION This invention relates to the field of protein tyrosine phosphatase inhibition. BACKGROUND OF THE INVENTION This invention relates to a novel class of phosphonic acid derivatives that are inhibitors of PTP-1B. Reversible protein tyrosine phosphorylation, coordinated by the

Protein tyrosine phosphatase inhibitors and methods of use thereof

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
FIELD OF THE INVENTION This invention relates to the field of protein tyrosine phosphatase inhibition. BACKGROUND OF THE INVENTION This invention relates to a novel class of phosphonic acid derivatives that are inhibitors of PTP-1B. Reversible protein tyrosine phosphorylation, coordinated by the

1,2,5-thiazolidine derivatives useful for treating conditions mediated by protein tyrosine phosphatases (PTPase)

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
This application is the National Stage of Application No. PCT/EP2006/046543, filed on Dec. 6, 2006, which claims benefit under 35 U.S.C. .sctn.119(a-d) of U.S. Provisional Application No. 60/748,491, filed Dec. 8, 2005, the contents of which are incorporated herein by reference in their

Oxindole hydrazide modulators of protein tyrosine phosphatases (PTPs)

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
FIELD OF THE INVENTION The present invention is related to the use of oxindole hydrazide derivatives of formula (I) for the treatment and/or prevention of metabolic disorders mediated by insulin resistance or hyperglycemia, comprising diabetes type I and/or II, inadequate glucose tolerance, insulin

Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (PTPs)

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
FIELD OF THE INVENTION The present invention is related to substituted methylene amide derivatives of formula (I), in particular for the treatment and/or prevention of metabolic disorders mediated by insulin resistance or hyperglycemia, comprising diabetes type I and/or II, inadequate glucose

Weight control product and method of treating hyperlipidemia and increasing vigor with said product

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
FIELD OF THE INVENTION This invention relates generally to a weight control product that is administered enterally to mammals in need of losing weight and/or reducing the blood plasma lipid levels. The weight control product comprises a mixture of guggul extract and phosphate salts. The inventive

Aromatic farnesyl compound and application thereof

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
REFERENCE TO CORRESPONDING APPLICATIONS The present application is the 371 national stage application based on International Application No. PCT/CN2015/097938, filed Dec. 18, 2015, which claims priority to Chinese Patent Application No. 20151057895.1, filed Sep. 11, 2015, Chinese Patent Application

Azole compound and medicinal use thereof

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
TECHNICAL FIELD The present invention relates to a novel azole compound, more particularly, the present invention relates to an azole compound or a pharmaceutically acceptable salt thereof having a protein tyrosine phosphatase 1B (PTP1B) inhibitory activity, and a pharmaceutical composition

Depsipeptides and drugs containing the same as the active ingredient

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
TECHNICAL FIELD This invention relates to a novel depsipeptide and a pharmaceutical preparation containing the same as an active ingredient. The depsipeptides of the invention have a promoting activity on the production of apolipoprotein E, and they are useful as a therapeutic agent for neurologic

1-orthofluorophenyl substituted 1,2,5-thiazolidinedione derivatives as PTP-as inhibitors

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
The present invention relates to thiadiazolidinone derivatives, pharmaceutical compositions containing such compounds, methods of making such and methods of treating conditions mediated by protein tyrosine phosphatases by employing such compounds. Accordingly, the present invention provides

Organic compounds

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
The present invention relates to thiadiazolidinone derivatives, pharmaceutical compositions containing such compounds, methods of making such and methods of treating conditions mediated by protein tyrosine phosphatases by employing such compounds. Accordingly, the present invention provides
Придружите се нашој
facebook страници

Најкомплетнија база лековитог биља подржана науком

  • Ради на 55 језика
  • Биљни лекови потпомогнути науком
  • Препознавање биљака по слици
  • Интерактивна ГПС мапа - означите биље на локацији (ускоро)
  • Читајте научне публикације повезане са вашом претрагом
  • Претражите лековито биље по њиховим ефектима
  • Организујте своја интересовања и будите у току са истраживањем вести, клиничким испитивањима и патентима

Упишите симптом или болест и прочитајте о биљкама које би могле да помогну, укуцајте неку биљку и погледајте болести и симптоме против којих се користи.
* Све информације се заснивају на објављеним научним истраживањима

Google Play badgeApp Store badge